Next 10 |
home / stock / dva / dva articles
New York, United States, July 16, 2024 (GLOBE NEWSWIRE) -- As per the Latest Report by Straits Research, the global renal denervation devices ma...
Quest Diagnostics (NYSE: DGX) recently announced a definitive agreement to purchase the select assets of OhioHealth's outreach laboratory servi...
Shares of Baxter International (NYSE: BAX) have gained 2.8% since Jun 26, after the company announced the recall of its Life2000 Ventilation S...
Glaukos Corporation (NYSE: GKOS) is well-poised for growth on the back of favorable clinical trial results and a robust product pipeline. However, ...
GE Healthcare Technologies, Inc. (NASDAQ: GEHC), in collaboration with the University of Cincinnati (UC), UC Health, and Cincinnati Children's,...
GE HealthCare Technologies Inc. (NASDAQ: GEHC), along with Heart Hospital of New Mexico at Lovelace Medical Center (HHNM), announced HHNM as the fi...
West Pharmaceutical Services, Inc. (NYSE: WST) is well poised for growth, backed by the robust Proprietary Products segment and sustained strength ...
McKesson Corporation's (NYSE: MCK) Biologics by McKesson, its independent specialty pharmacy specializing in oncology and rare disease areas, h...
BrainsWay Ltd. (NASDAQ: BWAY) recently signed an exclusive multi-year distribution agreement with a specialty distributor serving both the acute ho...
News, Short Squeeze, Breakout and More Instantly...
DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call PR Newswire DENVER , July 18, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, Aug...
2024-06-21 02:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...